Home 2019
Archives
Nivolumab Therapy Prolongs Survival in Advanced Melanoma
Overall survival at five years longer with nivolumab + ipilimumab, nivolumab alone versus ipilimumab
Less Bleeding With Ticagrelor Alone in High-Risk Patients
Less bleeding with ticagrelor alone versus ticagrelor plus aspirin for patients after PCI
Outcomes Similar With Hip Arthroplasty, Hemiarthroplasty
Incidence of secondary hip procedure within 24 months of follow-up did not differ between groups
Vitamin D Deficiency Linked to Increased Mortality
Association strongest in younger and middle-aged groups and for diabetes-related deaths
Vasomotor Symptoms in Women Tied to Higher Risk for CVD Events
Frequent baseline VMS linked to higher risk for later CVD events; more visits also linked to CVD events
Dapagliflozin Lowers Risk for Worsening Heart Failure
Findings seen among patients with heart failure, reduced ejection fraction, irrespective of diabetes
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
11 Percent of Cancers Detected Via Emergency Department Visit
Patients with ED-mediated diagnoses more likely to be unmarried, Hispanic or black, in lowest income quartile
Colorectal Cancer Mortality Disparities Vary Across U.S. Cities
Racial disparities in 25 of 30 cities examined; highest disparity in Washington, D.C., lowest in Philadelphia
Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes
Linagliptin compared with glimepiride for risk for major cardiovascular events in T2DM with elevated CV risk
